Breadcrumb Home Alzheimer's Disease Government FDA approves Alzheimer's drug for mild, early-stage disease Supply Chain Amid scrutiny FDA hits slowdown on accelerated drug approvals Technology Robotic pets offer companionship to seniors Opinion How government funding bills are strengthening America’s health Technology Addressing the ‘Trust Factor’: South Carolina researchers tackle health disparities using genetics Medicare CMS to adjust Medicare premiums in 2023 due to lower Aduhelm costs Mergers & Acquisitions Rensselaer, Mount Sinai partner on center to tackle uncured diseases Supply Chain Change at the top for Biogen after Alzheimer's drug flops Insurance UnitedHealthcare to limit Aduhelm access Medicare Medicare finalizes policy restricting Aduhelm coverage to clinical trial patients Load More Sponsored Content